Thursday, March 26, 2020 Daily Archives

Vaccine production plant forms part of Canada’s COVID-19 response

by

The University of Saskatchewan’s (USask) has received funding from the Canadian government to construct a pilot manufacturing plant to support trials of a COVID-19 vaccine candidate. Like many governments, Canada’s is ploughing funds into tackling the coronavirus pandemic currently sweeping the globe. A CAD 275 million ($195 million) fund for COVID-19 health research has been announced, and includes several investment in USask’s Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), which it says is one of the largest and most…

March 26, 2020

US FDA suspends all domestic GMP surveillance inspections

by

Agency responds to COVID-19 pandemic’s US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections. The US Food and Drug Administration (FDA) announced a suspension of all domestic good manufacturing practice surveillance and non-critical for-cause and preapproval inspections for the duration of the COVID-19 public health crisis as part of decision to require all eligible employees to telework. The aim is to wind down all inspections by 3 April. Exceptions will be made for inspections of facilities…

March 26, 2020